The 25th Neuronal Plasticity Prize of the Fondation Ipsen Has Been Awarded to Barry J. Everitt (Cambridge, UK), George F. Koob (La Jolla, USA) and Michel Le Moal (Bordeaux, France)
PARIS--(BUSINESS WIRE)--The 25th annual Neuronal Plasticity Prize of the Fondation
Ipsen has been awarded to three researchers for their pioneer works in
the domain of “Neuropsychology of drug addiction”: Barry J. Everitt (University
of Cambridge, Cambridge, UK), George F. Koob (The Scripps
Research Institute, La Jolla, USA) and Michel Le Moal (Inserm
U862, Bordeaux, France).
About Vermox (Mebendazole) with free prescription The €60,000 prize was awarded on July 8,
2014 at the FENS (Federation of European Neuroscience Societies) in
Milano by an international jury led by Professor Nikos Logothetis (Max
Planck Institute for Biological Cybernetics, T"ubingen, Germany).
About the laureates
Barry Everitt is Professor and Director of Research, and Provost
of the Gates Cambridge Trust, at the University of Cambridge.
Viagra (Sildenafil Citrate) without prescription He
graduated from Hull University with a B.Sc.
Topamax (Topiramate) without prescription in Zoology (1967) and
completed his Ph.D.
About Ciza with free Rx in behavioural neuroendocrinology at the University
of Birmingham Medical School in 1970.
Buy Malic Acid Combos online Following formative, postdoctoral
neuroscience research at the Karolinska Institutet in Stockholm
(1973-1974), he was appointed lecturer, then Reader in Neuroscience in
the Department of Anatomy, University of Cambridge.
http://futurepharmaceuticals.wordpress.com He moved to the
Department of Experimental Psychology in Cambridge in 1995 and was
appointed Professor of Behavioural Neuroscience. He was elected a Fellow
of the Royal Society in 2007, Fellow of the Academy of Medical Sciences
in 2008, and a Member of EMBO in 2014.
As a behavioural neuroscientist, Barry Everitt’s research has
always been concerned with understanding the neural mechanisms of
motivation, learning and memory, especially in the context of drug
addiction. His laboratory has made fundamental discoveries on the limbic
corticostriatal systems mediating pavlovian and instrumental learning
and memory mechanisms that underlie the seeking and taking of addictive
drugs. He also has a major interest in the molecular and systems basis
of memory reconsolidation of addictive drug and fear memories and the
potential of targeting maladaptive memories in the treatment of
neuropsychiatric disorders, including addiction. He has been President
of the British Association for Psychopharmacology (1992-1994), the
European Brain and Behaviour Society (1998-2000), and the European
Behavioural Pharmacology Society (2003-2005). He was Editor-in-Chief of
the European Journal of Neuroscience (1997-2008) and is a Reviewing
Editor for the journal Science. He has received many awards, including
the Distinguished Scientific Contribution Award of the American
Psychological Association (2011), the Distinguished Scientific
Achievement Award of the European Behavioural Pharmacology Society
(2011), and the FENS-EJN Award of the Federation of European
Neuroscience Societies (2012).
George F. Koob, Ph.D. is Director of the National Institute on
Alcohol Abuse and Alcoholism of the National Institutes of Health,
Washington, DC. As an authority on alcoholism, drug addiction and
stress, he has contributed to our understanding of the neurocircuitry
associated with the acute reinforcing effects of alcohol and drugs of
abuse and the neuroadaptations of the reward and stress circuits
associated with the transition to dependence. Dr. Koob has published
over 600 peers reviewed papers and several books including the
Neurobiology of Addiction, a comprehensive treatise on emerging research
in the field.
Michel Le Moal is Professor Emeritus of Neuroscience at the
University of Bordeaux. He graduated in Medicine (M.D. in 1962), in
philosophy-sociology and in natural sciences and then in neurology
(1967) and psychiatry (1968). He completed a Doctorate in Science at the
University of Bordeaux in 1974. In parallel with his academic life in
Bordeaux, he spent some years as associate researcher or professor in
Caltech (Pasadena) first, Jim Olds laboratory (1974-1976) and at the
Salk Institute and Scripps Research Institute (San Diego) in Floyd Bloom
and George Koob laboratories (1979-1994). In both institutions, he
worked on dopamine neurons electrophysiology and then, on the roles of
brain CRF and dopamine systems on behavior and drug addiction. His
research interests concern behavior and adaptive processes, their
biological foundations and experimental psychopathology a discipline he
tried to promote. The concept of individual vulnerability to behavioral
pathologies has been at the center of his working hypotheses. Michel Le
Moal has been the founder and director of several research laboratories
in CNRS and Inserm and finally of the Magendie Institute for
Neuroscience and Biological Psychiatry in Bordeaux. He is an elected
fellow of the French National Academy of Sciences
About the Neuronal Plasticity Prize
Founded in 1990, the Neuronal Plasticity Prize of La Fondation Ipsen
has been awarded to renowned specialists: Albert Aguayo (Montr eal,
1990), Anders Bj"orklund (Lund, 1990), Fred Gage (La Jolla,
1990), Ursula Bellugi (La Jolla, 1991), Wolf Singer (Frankfurt,
1990), Torsten Wiesel (New York, 1991), Philippe Ascher (Paris,
1992), Kjell Fuxe (Stockholm, 1992), Terje Lomo (Oslo,
1992), Per Andersen (Oslo, 1993), Masao Ito (Wako Saitama,
1993), Constantino Sotelo (Paris, 1993), Mariano Barbacid (Princeton,
1994), Yves Barde (Planegg-Martinsried, 1994), Hans Thoenen (Planegg-Martinsried,
1994), Jacques Mehler (Paris, 1995), Brenda Milner (Montreal,
1995), Mortimer Mishkin (Bethesda, 1995), Friedrich
Bonhoeffer (Tubingen, 1996), Corey Goodman (Berkeley, 1996), Marc
Tessier-Lavigne (San Francisco, 1996), Antonio Damasio (Iowa
City, 1997), Richard Frackowiac (London, 1997), Michael
Merzenich (San Francisco, 1997), Heinrich Betz (Frankfurt,
1998), Gerald Fischbach (Boston, 1998), Uel McMahan (Stanford,
1998), Masakazu Konishi (Pasadena, 1999), Peter Marler (Davis,
1999), Fernando Nottebohm (Millbrook, 1999), Tomas H"okfelt (Stockholm,
2000), Lars Olson (Stockholm, 2000), Lars Terenius (Stockholm,
2000), Albert Galaburda (Boston, 2001), John Morton (Londres,
2001), Elisabeth Spelke (Cambridge, USA, 2001), Arturo
Alvarez-Buylla (San Francisco, 2002), Ronald Mc Kay (Bethesda,
2002), Sam Weiss (Calgary, 2002), Francois Clarac (Marseille,
2003), Sven Grillner (Stockholm, 2003), Serge Rossignol (Montr eal,
2003), James Gusella (Boston, 2004), Jean-Louis Mandel (Strasbourg,
2004), Huda Y. Zoghbi (Houston, 2004), Ann Graybiel (Cambridge,
USA, 2005), Trevor Robbins (Cambridge, UK, 2005), Wolfram
Schultz (Cambridge, UK, 2005, Eckhart D. Gundelfinger (Magdeburg,
2006), Mary B. Kennedy (Pasadena, 2006), Morgan Sheng (Cambridge,
USA, 2006), Nikos K. Logothetis (T"ubingen, 2007), Keiji
Tanaka (Wako, 2007), Giacomo Rizzolati (Parma, 2007), Jean-Pierre
Changeux (Paris, 2008), Peter W. Kalivas (Charleston 2008), Eric
J. Nestler (Dallas, 2008), Alim-Louis Benabid (Grenoble, 2009),
Apostolos P. Georgopoulos (Minneapolis, 2009) , Miguel A. L.
Nicolelis (Durham, 2009), Thomas Insel (Bethesda, 2010), Bruce
Mc Ewen (New York, 2010) and Donald Pfaff (New York, 2010), Helen
Neville (Eugene, 2011), Isabelle Peretz (Montreal, 2011), Robert
Zatorre (Montreal, 2011), Catherine Dulac (Boston, 2012), Richard
G. Morris (Edinburgh, 2012), J. David Sweatt (Birmingham,
2012), Tim V.P. Bliss (London, 2013), Richard G. M. Morris (Edinburgh,
2013), Yadin Dudai (Rehovot, 2013).
The jury: Albert Aguayo (Montreal General Hospital, Montr eal,
Canada), Jo"el Bockaert (Institut de G enomique Fonctionnelle,
Montpellier, France), Alexis Brice (H^opital de la Salp`etri`ere,
Paris, France), Stanislas Dehaene (Inserm U562, Orsay, France),
Stephen Dunnett (Cardiff University, Cardiff, UK), Kjell Fuxe (Karolinska
Institute, Stockholm, Sweden), Christine Petit (Institut Pasteur,
Paris, France), Wolf Singer (Max-Planck Institute for Brain
Research, Frankfurt, Germany).
About the Fondation Ipsen
Founded in 1983 under the aegis of the Fondation de France, the
Fondation Ipsen is dedicated to contributing to the development and
dissemination of scientific knowledge. The long-standing action of the
Fondation Ipsen aims to promote the interaction between researchers and
clinicians, essential exchanges because of the extreme specialization of
these professions. The ambition of the Fondation Ipsen is to initiate a
reflection about the major scientific issues of the forthcoming years.
The Fondation has developed a significant international network of
scientific experts, who meet regularly at Colloques M edecine et
Recherche, dedicated to five main themes: Alzheimer s disease,
neuroscience, longevity, endocrinology and cancer. Furthermore, since
2007 the Fondation Ipsen has introduced several series of meetings in
partnership with the Salk Institute, the Karolinska Institutet,
Massachusetts General Hospital, the DMMGF Foundation, as well as with
the journals Nature, Cell and Science. The
Fondation Ipsen has published over one hundred books and has awarded
more than 250 prizes and grants. More information can be found on the
website: .fondation-ipsen.org